Cost-effectiveness analysis of durvalumab plus chemotherapy as first-line treatment for biliary tract cancer
Zhuomiao Ye, Zhe Xu, Huan Li, Qian Li
2023Frontiers in Public Health18 citations Open access
Semantic Scholar
Researcher profile · Semantic Scholar
Zhuomiao Ye, Zhe Xu, Huan Li, Qian Li
Zhe Xu, Zhuomiao Ye, Yu-Kai Tang, Dong-Feng Deng +4 more
Zhuomiao Ye, Ziwei Tang, Zhe Xu, Qin C. Zhou +1 more
Jia Hu, Zhe Xu, Zhuomiao Ye, Jin Li +2 more
Jia Hu, Zhuomiao Ye, Zhe Xu, Zhinan Hao +1 more
Zhuomiao Ye, Zhe Xu, Hao-lun Wang, Yingying Wang +4 more
Zhuomiao Ye, Zhe Xu, Fan Zeng, Zi-Long Tang +1 more
Dong-Feng Deng, Qin Zhou, Zhuomiao Ye, Zhe Xu +1 more
Hao-lun Wang, Zhuomiao Ye, Zi-Qin He, Lu Huang +1 more
Yu-Kai Tang, Zhe Xu, Zhuomiao Ye, Shiran Li +1 more
Ying-Yuan Wang, Ze Chen, Lu-Xing Zhang, Shuang R. Chen +3 more
Dong-Feng Deng, Qin Zhou, Zhuomiao Ye, Zhe Xu +1 more